Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient.

Literature DB >> 19420177

Life-threatening infection caused by daptomycin-resistant Corynebacterium jeikeium in a neutropenic patient.

Christoph Schoen¹, Christian Unzicker, Gernot Stuhler, Johannes Elias, Hermann Einsele, Götz Ulrich Grigoleit, Marianne Abele-Horn, Stephan Mielke.

Abstract

Daptomycin is a novel lipopeptide antibiotic agent approved for the treatment of gram-positive life-threatening infections. Here we report, for the first time, the isolation of a highly daptomycin-resistant strain of Corynebacterium jeikeium causing a life-threatening infection in a neutropenic patient undergoing cord blood transplantation for secondary acute myeloid leukemia.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19420177 PMCID： PMC2708472 DOI： 10.1128/JCM.00457-09

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

19 in total

1. Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and putative pathogens.

Authors: Gerhard Hutter; Ulrich Schlagenhauf; Giuseppe Valenza; Matthias Horn; Stefan Burgemeister; Heike Claus; Ulrich Vogel
Journal: Microbiology (Reading) Date: 2003-01 Impact factor: 2.777

2. Mechanisms of resistance to daptomycin in Enterococcus faecium.

Authors: Clemente I Montero; Frida Stock; Patrick R Murray
Journal: Antimicrob Agents Chemother Date: 2008-01-07 Impact factor: 5.191

3. Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycin.

Authors: Juliet Elvy; David Porter; Erwin Brown
Journal: J Antimicrob Chemother Date: 2007-12-21 Impact factor: 5.790

4. Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin.

Authors: Daniel J Skiest
Journal: J Clin Microbiol Date: 2006-02 Impact factor: 5.948

5. Genome and virulence determinants of high virulence community-acquired MRSA.

Authors: Tadashi Baba; Fumihiko Takeuchi; Makoto Kuroda; Harumi Yuzawa; Ken-ichi Aoki; Akio Oguchi; Yoshimi Nagai; Natsuko Iwama; Kazuyuki Asano; Timothy Naimi; Hiroko Kuroda; Longzhu Cui; Kenji Yamamoto; Keiichi Hiramatsu
Journal: Lancet Date: 2002-05-25 Impact factor: 79.321

6. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia.

Authors: N Kvirikadze; M Suseno; T Vescio; L Kaminer; K Singh
Journal: Scand J Infect Dis Date: 2006

7. Molecular epidemiology of hospital-acquired vancomycin-resistant enterococci.

Authors: Marianne Abele-Horn; Ulrich Vogel; Ingo Klare; Carola Konstabel; Rene Trabold; Risa Kurihara; Wolfgang Witte; Wolfgang Kreth; Paul-Gerhardt Schlegel; Heike Claus
Journal: J Clin Microbiol Date: 2006-09-27 Impact factor: 5.948

Review 8. Epidemiology of methicillin-resistant staphylococci in Europe.

Authors: S Stefani; P E Varaldo
Journal: Clin Microbiol Infect Date: 2003-12 Impact factor: 8.067

9. Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors: R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal: JAMA Date: 2007-10-17 Impact factor: 56.272

10. Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms.

Authors: Jennifer M Streit; Ronald N Jones; Helio S Sader
Journal: J Antimicrob Chemother Date: 2004-02-25 Impact factor: 5.790

10 in total

1. Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?

Authors: Truc T Tran; Siraya Jaijakul; Cole T Lewis; Lorena Diaz; Diana Panesso; Heidi B Kaplan; Barbara E Murray; Audrey Wanger; Cesar A Arias
Journal: Antimicrob Agents Chemother Date: 2012-03-26 Impact factor: 5.191

Review 2. Mechanisms of drug resistance: daptomycin resistance.

Authors: Truc T Tran; Jose M Munita; Cesar A Arias
Journal: Ann N Y Acad Sci Date: 2015-10-23 Impact factor: 5.691

3. Toll-Like Receptor 2 and Mincle Cooperatively Sense Corynebacterial Cell Wall Glycolipids.

Authors: Judith Schick; Philipp Etschel; Rebeca Bailo; Lisa Ott; Apoorva Bhatt; Bernd Lepenies; Carsten Kirschning; Andreas Burkovski; Roland Lang
Journal: Infect Immun Date: 2017-06-20 Impact factor: 3.441

4. Evaluating the Rapid Emergence of Daptomycin Resistance in Corynebacterium: a Multicenter Study.

Authors: Kaitlin F Mitchell; Erin McElvania; Meghan A Wallace; Lauren E Droske; Amy E Robertson; Lars F Westblade; C A Burnham
Journal: J Clin Microbiol Date: 2021-03-19 Impact factor: 5.948

Review 5. Antibiotic Therapy for Prosthetic Joint Infections: An Overview.

Authors: Benjamin Le Vavasseur; Valérie Zeller
Journal: Antibiotics (Basel) Date: 2022-04-05

Review 6. A current perspective on daptomycin for the clinical microbiologist.

Authors: Romney M Humphries; Simon Pollett; George Sakoulas
Journal: Clin Microbiol Rev Date: 2013-10 Impact factor: 26.132

7. In Vitro Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016.

Authors: Julianne V Kus; Samir N Patel; Alefiya Neemuchwala; Deidre Soares; Vithusha Ravirajan; Alex Marchand-Austin
Journal: Antimicrob Agents Chemother Date: 2018-03-27 Impact factor: 5.191